Laurence Mulard
9Patents
1h-index
25Co-inventors
47Inventor score
Filing activity: Jul 2, 2004 → Sep 30, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8124380B2 | Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri | Emerging Cross-Sectional Technologies | 6 | Active |
| US7820142B2 | Immunogenic glycopeptides, screening, preparation and uses | Physics | 1 | Active |
| US10376593B2 | Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri | Emerging Cross-Sectional Technologies | 0 | Active |
| US11834468B2 | Protected tetrasaccharides, their process of preparation and their use as transglucosylase acceptor substrates in the chemo-enzymatic synthesis of Shigella flexneri specific oligosaccharides | Chemistry; Metallurgy | 0 | Active |
| US10822398B2 | Polyclonal antibodies specific for serogroup x of N. meningitidis and uses thereof in diagnosis | Physics | 0 | Active |
| US11618781B2 | Polyclonal antibodies specific for serogroup X of N. meningitidis and uses thereof in diagnosis | Physics | 0 | Active |
| US9446109B2 | Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri | Emerging Cross-Sectional Technologies | 0 | Active |
| US8815239B2 | Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X | Chemistry; Metallurgy | 0 | Active |
| US10087242B2 | Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.